Mast Therapeutics, Inc. (MSTX)

[pray]

There are so many factors it is almost impossible for a layperson to know unless all drug potentials formulated. Think this way ... You combine the values of the companies along with any outstanding debts.

Remember MSTX had no debt, in fact has over 20 million in cash to use on future testing. Along with this fact their loan drug is getting already about approximately 80% financed through the government.

Say MSTX has 200 million shares.

So you have 2000 shares of mstx at .20 cents values at $400

There is a 20/1 Reverse Split where now you have only 100 shares at $4.00 valued at a total of still $400.

Rather than 200 million shares there is only 20 million now.

If you have a private company and own one share of Savara at $4.00 you are voting on how many shares it increses (one now is 1.2, 1.5, 1.7?). So your $4.00 now $4.50 or $5.00.

You have 2 companies combining pipelines (MSTX 1, Savara 4) drug possibilities with market financing.